2024-04-25 08:19:01 ET
More on Regeneron Pharmaceuticals
- Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate
- Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Regeneron to 'vigorously defend' against DOJ on Eylea pricing complaint
- Regeneron hits three-month low after DOJ complaint; RBC defends
Read the full article on Seeking Alpha
For further details see:
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies